Mechanisms and Impact of Islet Vascular Inflammation in Diabetes

糖尿病胰岛血管炎症的机制和影响

• 批准号: 10589674
• 负责人: REBECCA LUCY HULL-MEICHLE
• 金额: --
• 依托单位: VA PUGET SOUND HEALTHCARE SYSTEM
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-01-01 至 2026-12-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10589674
• 关键词: 3-Dimensional; Address; Affect; Amputation; Amyloid; Animal Model; Beta Cell; Blindness; Blood Vessels; Blood capillaries; Blood flow; Brain; C-Type Lectins; Cell Death; Cell Survival; Cell model; Cell physiology; Cells; Crossbreeding; Data; Defect; Deposition; Development; Diabetes Mellitus; Diabetic Nephropathy; Diabetic Retinopathy; End stage renal failure; Endothelial Cells; Endothelium; Extracellular Matrix; Extravasation; Failure; Family; Functional disorder; Health; Healthcare Systems; Homeostasis; Human; Hyperglycemia; Impairment; In Vitro; Inflammation; Insulin; Islet Cell; Islets of Langerhans; Knowledge; Mediating; Mediator; Microvascular Dysfunction; Modeling; Molecular; Mus; Non-Insulin-Dependent Diabetes Mellitus; Nutrient; Pancreas; Paracrine Communication; Pathogenesis; Pathology; Pathway interactions; Patients; Pericytes; Peripheral; Play; Population; Predisposition; Role; Signal Transduction; Slice; Source; Tissues; Toxic effect; Transgenic Mice; Vascular Diseases; Vascularization; Veterans; Work; cell type; cytotoxicity; endocrine pancreas development; human data; in vivo; islet; islet amyloid polypeptide; kidney fibrosis; member; neuroinflammation; novel; prevent; response; targeted treatment; transcriptome sequencing; vascular abnormality; vascular inflammation

Insufficient release of insulin from the pancreatic islet β cell is a critical defect in type 2 diabetes (T2D). Pancreatic islets are highly vascularized, and this vasculature is essential for nutrient supply to islet cells, insulin delivery to peripheral tissues and as a rich source of signals that support β-cell function. In human T2D and animal models, islet vasculopathy manifests as endothelial inflammation and capillary dilation and fragmentation. Moreover, induction of these islet vascular abnormalities in vitro is sufficient to impair insulin release and/or induce β-cell death. We have identified human islet amyloid polypeptide (hIAPP) aggregation as a mediator of islet vasculopathy. hIAPP-derived amyloid deposits accumulate in the extracellular matrix between β cells and islet capillaries in almost all patients with T2D. We now show that hIAPP aggregation results in islet endothelial cell cytotoxicity and inflammation, capillary dilation and loss. Using, RNA-Seq we identified Clec14a as a potential molecular mediator of hIAPP-induced islet endothelial damage. Clec14a is a member of the vascular C-type lectin family, whose pancreatic expression is restricted to endothelial cells. Clec14a deficiency has been shown to result in microvascular destabilization, inflammation and cell death in several tissues but has never been studied in the pancreas. We will now determine if loss of Clec14a exacerbates the islet endothelial response to hIAPP in vitro and increases susceptibility to hIAPP-induced islet vasculopathy and exacerbates β-cell dysfunction in vivo. Capillary-associated pericytes play a critical role in normal microvascular homeostasis. In several tissues, including islets, pericytes regulate capillary tone and blood flow. Pericyte coverage is also necessary for endothelial integrity, pericyte-endothelial interactions prevent endothelial inflammation and vessel leakage. This interaction, in non-islet tissues, is governed both by paracrine signals and cell-cell contact, of which Clec14a is just one mediator. Disruption of endothelial-pericyte interactions underlies the vascular instability and inflammation that drives development of diabetic retinopathy and renal fibrosis. Pericyte detachment/loss also occurs in T2D islets. However, the mechanisms that govern islet endothelial-pericyte attachment, how these are disrupted in T2D and the consequent impact on β-cell function have not been studied. This proposal will address this major knowledge gap. Our preliminary data show that hIAPP aggregation leads to islet pericyte detachment and degeneration. Our data and others’ show this includes a direct toxic effect of hIAPP on microvascular pericytes, resulting in loss of key signals that govern endothelial cell-pericyte cross-talk. This proposal will address the hypothesis that disruption of islet endothelial cell-pericyte interactions, mediated in part by Clec14a deficiency, underlies hIAPP-induced islet vasculopathy and contributes to β-cell dysfunction. We propose three aims to address this hypothesis: Aim 1. To determine whether Clec14a deficiency mediates the deleterious vascular effects of aggregated IAPP in vitro and exacerbates hIAPP-induced islet vasculopathy and β-cell dysfunction in vivo. Aim 2. To determine the role of islet endothelial cell-pericyte interactions in mediating deleterious effects of hIAPP aggregation in vitro. Aim 3. To determine the impact of aggregated hIAPP on islet pericyte function ex vivo and identify islet endothelial cell/pericyte-derived mediators of impaired insulin release and β-cell death in vitro. These novel studies will be the first to investigate Clec14a in the pancreas, and to interrogate mechanisms governing islet endothelial cell-pericyte interactions under normal conditions and following hIAPP aggregation. This work is significant as it could lead to development of new vascular-targeted therapies which could treat β- cell dysfunction and may also be relevant for the microvascular disease which affects many tissues in T2D.

胰岛β细胞释放胰岛素不足是2型糖尿病（T2D）的一个关键缺陷。